Medytox is growing as the No. 1 medical aesthetic company.
Botulinum Toxin Type A Product Meditoxin® (Neuronox)
Neuronox® 50U
export name :
Neuronox® 100U
export name :
Neuronox® 150U
export name :
Neuronox® 200U
export name :
-
Active Ingredient
- Clostridium botulinum toxin type A (Hall strain)
-
Description
- a lyophilized white powder for injection in a colorless transparent vial
-
Storage Condition
- Store at -15 ~ -5℃ or at 2 ~ 8℃ in a refrigerator, in hermetic container
-
Package Unit
- 1 vial
-
Expiry Date
- 36 months from the manufacturing date
-
Indication and Usage
- Benign essential blepharospasm in adults aged 18 or more
- To treat foot deformities due to spasticity in pediatric cerebral palsy patients aged 2 or older
- To temporarily improve moderate to severe glabellar lines related to eyebrow wrinkle muscle (corrugator muscle) and/or procerus muscle activity in adults aged from 20 to 65
- Muscle spasticity: upper limb local muscle spasticity related to stroke in adults aged 20 or more
- Treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain
-
Active Ingredient
- Clostridium botulinum toxin type A (Hall strain)
-
Description
- a lyophilized white powder for injection in a colorless transparent vial
-
Storage Condition
- Store at -15 ~ -5℃ or at 2 ~ 8℃ in a refrigerator, in hermetic container
-
Package Unit
- 1 vial
-
Expiry Date
- 24 months from the manufacturing date
-
Indication and Usage
- Benign essential blepharospasm in adults aged 18 or more
- To treat foot deformities due to spasticity in pediatric cerebral palsy patients aged 2 or older
- To temporarily improve moderate to severe glabellar wrinkles related to eyebrow wrinkle muscle (corrugator muscle) and/or procerus muscle activity in adults aged from 20 to 65
- Muscle spasticity: upper limb local muscle spasticity related to stroke in adults aged 20 or more
- Treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain
-
Active Ingredient
- Clostridium botulinum toxin type A (Hall strain)
-
Description
- a lyophilized white powder for injection in a colorless transparent vial
-
Storage Condition
- Store at -15 ~ -5℃ or at 2 ~ 8℃ in a refrigerator, in hermetic container
-
Package Unit
- 1 vial
-
Expiry Date
- 36 months from the manufacturing date
-
Indication and Usage
- Benign essential blepharospasm in adults aged 18 or more
- To treat foot deformities due to spasticity in pediatric cerebral palsy patients aged 2 or older
- To temporarily improve moderate to severe glabellar wrinkles related to eyebrow wrinkle muscle (corrugator muscle) and/or procerus muscle activity in adults aged from 20 to 65
- Muscle spasticity: upper limb local muscle spasticity related to stroke in adults aged 20 or more
- Treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain
-
Active Ingredient
- Clostridium botulinum toxin type A (Hall strain)
-
Description
- a lyophilized white powder for injection in a colorless transparent vial
-
Storage Condition
- Store at -15 ~ -5℃ or at 2 ~ 8℃ in a refrigerator, in hermetic container
-
Package Unit
- 1 vial
-
Expiry Date
- 36 months from the manufacturing date
-
Indication and Usage
- Benign essential blepharospasm in adults aged 18 or more
- To treat foot deformities due to spasticity in pediatric cerebral palsy patients aged 2 or older
- To temporarily improve moderate to severe glabellar wrinkles related to eyebrow wrinkle muscle (corrugator muscle) and/or procerus muscle activity in adults aged from 20 to 65
- Muscle spasticity: upper limb local muscle spasticity related to stroke in adults aged 20 or more
- Treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain
You can find the recent approval updates and detailed information on MFDS(https://nedrug.mfds.go.kr).
COPYRIGHT © 2006-2024 Medytox. ALL RIGHTS RESERVED
